Browsing Category
Drug research
Doctors are excited by the melanoma vaccine trial results.
According to doctors, the world's first personalised cancer vaccine for melanoma reduces the risk that patients will die or have the disease return.
According to the 2020 statistics from World Research Fund International, melanoma…
AstraZeneca wants to double its revenues to $80 billion by 2030
AstraZeneca is the largest drug manufacturer in Britain. It has set a bold goal to achieve $80bn ($63bn) by 2030 through treatments for cancer and rare diseases.
Pascal Soriot, the chief executive of the company, presented the growth…
Novo Nordisk will test the effects of weight-loss drugs on alcohol consumption and liver disease.
Novo Nordisk wants to increase the use of its blockbuster treatments. It is testing their weight loss drugs to see if they reduce alcohol consumption and treat alcoholic hepatitis.
The Danish pharmaceutical company started recruiting for…
Sir John Bell, tsar of life sciences, believes that London is not the best place to raise funds.
Sir John Bell, one of Britain's leading life sciences leaders, warned of an imminent exodus of pharmaceutical companies from London, calling the City "a bad place to raise funds".
Sir John, a veteran of the industry known for his crucial…
Rare genetic disease treatment becomes the world’s most costly drug at $4.25mn
In the US, a new gene therapy that treats a rare genetic disorder that attacks the nervous system central of young children is priced at $4.25mn. This makes it the most costly drug in history.
Lenmeldy, a medicine developed by Orchard…
Novo-Nordisk gives me a boost with a double dose of power.
Most people prefer to take a pill rather than inject themselves with medication when they are sick. This simple fact helped Novo-Nordisk, (stock ticker:NOVO), to become the third-most valuable holding in my “forever fund” after renewed hope…
AstraZeneca purchases rare diseases group in order to boost drug pipeline
The largest pharmaceutical company in Britain has signed a deal to buy a French company that specializes in rare diseases for more than $1 billion. This is part of its efforts to boost the pipeline of drugs.
AstraZeneca agreed to…
AstraZeneca builds £450m vaccine center in Liverpool as boost for UK
AstraZeneca will spend £650m to build a new factory for vaccines in Liverpool, and upgrade research labs at Cambridge. This comes almost a full year after the chief executive of AstraZeneca said that Rishi Sunak’s policies discouraged…
Shares of Viking Therapeutics more than doubled on’statistically important’ weight loss…
The shares of US biotech Viking Therapeutics have more than doubled since trial results for its weight-loss drug beat existing treatments from Novo Nordisk & Eli Lilly.
In a mid-stage 13-week trial, Viking reported that its…
AstraZeneca unveils successes in treatment of lung cancer
AstraZeneca announced on Monday that its top drug has shown promising results in treating early-stage lung cancer by slowing down the progression of the disease.
The company announced that its Tagrisso drug, which is a best-seller,…
Eli Lilly to launch weight loss drug in UK ‘within a few weeks’
Mounjaro, a weight-loss drug that is available in an injectable pen in Great Britain in the near future for the treatment of diabetes and obesity will be made available by Eli Lilly after the UK medicines regulator approved its sale on…
Data shows that expired Pfizer Covid antiviral medications will cost Europe $2.2bn.
According to data from the European Health Agency, more than one billion dollars of Pfizer Covid-19 antiviral medications procured by Pfizer in Europe were wasted because strict controls on who could receive the medication led to millions…
Syntara’s $10M Raise: Fueling Drug Development
Syntara's $10M capital raise is propelling its drug development strategy into a new era.
In this exclusive interview, CEO Gary Phillips unveils the transformative steps taken by Syntara Ltd, from its rebranding efforts to the strategic…
AstraZeneca acquires US vaccine company for $1.1bn
AstraZeneca has acquired its first vaccine company for $1.1bn. This will allow the company to expand its vaccine and immunotherapy business, which it established during the Covid pandemic.
The largest drugmaker in Britain has agreed to…
Weight loss drug manufacturer plots a ‘buy Now, Pay Later’ offer
Novo Nordisk wants to help more people get Wegovy jabs, including those who are currently unable to access them.
Novo Nordisk, a maker of obesity drugs, said that it would offer countries the option to "buy now and pay later" for its…
AstraZeneca defends its Covid-19 injection against accusations that it was defective
AstraZeneca has contested accusations that the Covid-19 vaccine was "defective", after a vaccine patient sued for damages, claiming to have suffered a severe side-effect.
The Anglo-Swedish pharmaceutical company, which developed the…
AstraZeneca signs a deal for an oral obesity drug that boosts profit forecasts
AstraZeneca will enter the race to develop a weight-loss pill. It is working on a new class of drugs, which it hopes to use in developing nations to combat obesity.
The Anglo-Swedish pharmaceutical company announced on Thursday a…
Early drug treatment for Alzheimer’s disease is beneficial according to new studies
Researchers from Eisai and Eli Lilly presented a study that showed the benefits for patients of using new Alzheimer's medications very early in its development.
The Japanese pharmaceutical group Eisai has revealed that a new analysis…